XML 72 R60.htm IDEA: XBRL DOCUMENT v3.23.2
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of grants under share based payment - shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of grants under share based payment [Line Items]    
Number of awards 342,850 187,500
Maximum term (years) 4 years 4 years
Awards outstanding at the beginning of the reporting period 187,500
Awards granted in the reporting period 155,350 187,500
Awards forfeited in the reporting period (50,000)
Awards exercised in the reporting period (96,873)
Awards expired in the reporting period
Awards outstanding at the end of the reporting period 195,977 187,500
Awards exercisable at the end of the reporting period
Non-Qualified Stock Options [Member]    
Disclosure on individual items of the consolidated financial statements (Details) - Schedule of grants under share based payment [Line Items]    
Number of awards 1,457,375  
Maximum term (years) 4 years  
Awards outstanding at the beginning of the reporting period  
Awards granted in the reporting period 1,457,375  
Awards forfeited in the reporting period (135,792)  
Awards exercised in the reporting period  
Awards expired in the reporting period  
Awards outstanding at the end of the reporting period 1,321,583
Awards exercisable at the end of the reporting period 77,100